- Verrica Pharmaceuticals (NASDAQ:VRCA) on Wednesday announced that company experienced strong demand for YCANTH in the second quarter of 2025, with 13,434 dispensed applicator units during the quarter.
- These dispensed applicator units represent accelerating sequential growth of 32.8% over the first quarter of
Verrica Pharmaceuticals reports 13,434 YCANTH dispensed applicator units in Q2

Related
Apple reportedly wants to buy the streaming rights for Formu...
9 minutes ago
0
Elanco gets US Agriculture department nod for TruCan
16 minutes ago
0
Market Voices: Copper tariffs, mortgage volumes rise, Hims &...
26 minutes ago
0
EOG Resources cut at Roth on concerns that global oil prices...
29 minutes ago
0
Paysafe converts Peruvian eCash brand into digital wallet
43 minutes ago
0
Saratoga Investment signals 11.8% dividend yield and $430M i...
47 minutes ago
0
Linda Yaccarino becomes ex-X CEO one day after Grok spouts a...
48 minutes ago
0
First Majestic Silver rises on strong Q2 production, improve...
53 minutes ago
0
Inovio wins new Overweight at Piper Sandler on potential FDA...
54 minutes ago
0
CoreWeave’s $9 billion acquisition of Core Scientific gives ...
54 minutes ago
0
Perplexity launches AI-powered browser Comet
1 hour ago
0
SA Sentiment: No bitcoin crash likely this year
1 hour ago
0
PB Financial raises dividend by 1.7%
1 hour ago
0
Trending
Popular
© FBT Company 2025. All rights are reserved